Narrow Results Clear All
Search results for "Overtreatment"
Journal Article > Commentary
Overdiagnosis and overtreatment as a quality problem: insights from healthcare improvement research.
Armstrong N. BMJ Qual Saf. 2018;27:571-575.
Overdiagnosis and overtreatment can result in physical, financial, and emotional harm for patients. This commentary suggests applying quality improvement approaches to address overdiagnosis and overtreatment. Tactics discussed include clear articulation of the problem and contributing factors, use of theory-driven approaches for designing initiatives, and monitoring the impact of improvement efforts.
Szabo L. Kaiser Health News. October 23, 2017.
Overdiagnosis and overtreatment present a challenge to patient safety. This news article reports on the prevalence of overtreatment among patients with cancer, how it can result in patient harm, and patient stories that illustrate the impact of overtreatment. A past PSNet interview discussed the patient safety implications of diagnostic radiology overuse.
National Quality Partners. Washington, DC: National Quality Forum; 2016.
Antimicrobial stewardship has been promoted as a strategy to improve patient safety by reducing overuse of antibiotics to prevent hospital-acquired infections. This report draws from the experience of existing programs to summarize practical strategies for implementing initiatives. Core elements include engaging leadership, monitoring effectiveness, and reporting benchmarks.
Journal Article > Study
Yu DT, Seger DL, Lasser KE, et al. Pharmacoepidemiol Drug Saf. 2011;20:192-202.
Preventing overuse of potentially dangerous medications has continued to be a challenge for the safety movement, despite increasing use of technological solutions such as computerized order entry and clinical decision support. This study targeted prescribing for drugs classified as requiring a black box warning by implementing reminders within an ambulatory electronic medical record. Certain specific alerts, such as warning against prescribing drugs contraindicated in pregnancy or those with high potential for drug–drug interactions, were effective. However, overall prescribing of contraindicated medications did not decrease. Prior studies have also found limited benefit from prescribing reminders in ambulatory care, and a recent systematic review found that point-of-care clinician reminders, such as those used in this study, generally achieved only limited successes.